OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Diverse landscape of dermatologic toxicities from small‐molecule inhibitor cancer therapy
Riyad N. H. Seervai, Woo Cheal Cho, Emily Y. Chu, et al.
Journal of Cutaneous Pathology (2021) Vol. 49, Iss. 1, pp. 61-81
Open Access | Times Cited: 6
Riyad N. H. Seervai, Woo Cheal Cho, Emily Y. Chu, et al.
Journal of Cutaneous Pathology (2021) Vol. 49, Iss. 1, pp. 61-81
Open Access | Times Cited: 6
Showing 6 citing articles:
Erosive pustular dermatosis-like eruption of the scalp secondary to amivantamab: A case series
Mariya N. George, Riyad N. H. Seervai, Susan Y. Chon
JAAD Case Reports (2024) Vol. 47, pp. 72-79
Open Access | Times Cited: 4
Mariya N. George, Riyad N. H. Seervai, Susan Y. Chon
JAAD Case Reports (2024) Vol. 47, pp. 72-79
Open Access | Times Cited: 4
Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings
Dylan Haynes, Eric E. Morgan, Emily Y. Chu
Human Pathology (2023) Vol. 140, pp. 129-143
Closed Access | Times Cited: 5
Dylan Haynes, Eric E. Morgan, Emily Y. Chu
Human Pathology (2023) Vol. 140, pp. 129-143
Closed Access | Times Cited: 5
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune‐related adverse event reveal upregulation of toll‐like receptor 4/complement‐induced innate immune response and increased density of TH1 T‐cells
Mario L. Marques‐Piubelli, Riyad N. H. Seervai, Kumaran Mudaliar, et al.
Journal of Cutaneous Pathology (2023) Vol. 50, Iss. 7, pp. 661-673
Closed Access | Times Cited: 2
Mario L. Marques‐Piubelli, Riyad N. H. Seervai, Kumaran Mudaliar, et al.
Journal of Cutaneous Pathology (2023) Vol. 50, Iss. 7, pp. 661-673
Closed Access | Times Cited: 2
The diverse landscape of dermatologic toxicities of non‐immune checkpoint inhibitor monoclonal antibody‐based cancer therapy
Riyad N. H. Seervai, Sarah Friske, Emily Y. Chu, et al.
Journal of Cutaneous Pathology (2022) Vol. 50, Iss. 1, pp. 72-95
Closed Access | Times Cited: 3
Riyad N. H. Seervai, Sarah Friske, Emily Y. Chu, et al.
Journal of Cutaneous Pathology (2022) Vol. 50, Iss. 1, pp. 72-95
Closed Access | Times Cited: 3
An exceptional case of imatinib mesylate inducing both psoriasis and lichenoid reaction: A case report
K. Belharti, Hasnae Saddouk, Nassiba Zerrouki, et al.
Journal of Cutaneous Pathology (2024)
Closed Access
K. Belharti, Hasnae Saddouk, Nassiba Zerrouki, et al.
Journal of Cutaneous Pathology (2024)
Closed Access
Bosutinib-Induced Stevens-Johnson Syndrome and Evidence of Tolerance to a Structurally Dissimilar Tyrosine Kinase Inhibitor
Karol Avila‐Castano, Dan Morgenstern‐Kaplan, Ismael Carrillo‐Martin, et al.
Cureus (2022)
Open Access | Times Cited: 1
Karol Avila‐Castano, Dan Morgenstern‐Kaplan, Ismael Carrillo‐Martin, et al.
Cureus (2022)
Open Access | Times Cited: 1
